Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Campos, Alline Cristina, Moreira, Fabricio Araújo, Gomes, Felipe Villela, Del Bel, Elaine Aparecida, Guimarães, Francisco Silveira·2012·Philosophical Transactions of the Royal Society B: Biological Sciences

Cited by (474)

Items 201–300 of 474

  1. Component of Cannabis, Cannabidiol, as a Possible Drug against the Cytotoxicity of Aβ(31–35) and Aβ(25–35) Peptides: An Investigation by Molecular Dynamics and Well-Tempered Metadynamics Simulations
    Wojciech Chrobak, Dawid Wojciech Pacut, Fredrik Blomgren, Alexander Rodin, Jan Swenson, Inna Ermilova · 2021 · ACS Chemical Neuroscience
  2. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum
    João Francisco Cordeiro Pedrazzi, Amanda J. Sales, Francisco Silveira Guimarães, Sâmia R.L. Joca, José A. Crippa, Elaine Aparecida Del Bel · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  3. Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
    João Luís Q. Simei, José Diogo R. Souza, João Francisco Cordeiro Pedrazzi, Francisco Silveira Guimarães, Alline Cristina Campos, Antônio Waldo Zuardi, Jaime E. C. Hallak, José Alexandre S. Crippa · 2024 · Pharmaceuticals
  4. Leading the Next CBD Wave—Safety and Efficacy
    Yasmin L. Hurd · 2020 · JAMA Psychiatry
  5. Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway
    Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée · 2021 · Molecular Psychiatry
  6. Role and Function of Endocannabinoid System in Major Depressive Disease
    Erhan Yarar · 2020 · Medical Cannabis and Cannabinoids
  7. Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression
    Uri Bright, Irit Akirav · 2023 · International Journal of Molecular Sciences
  8. Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study
    Yvonne Ann Bonomo, Amanda F. Norman, Lisa Collins, Helen O’Neill, Peter Galettis, Jane Trinca, Nigel H. M. Strauss, Jennifer H. Martin, David Jonathan Castle · 2021 · Pain and Therapy
  9. Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
    Gihyun Lee, Sun Kwang Kim · 2016 · Molecules
  10. Protective Effects of Cannabidiol (CBD) against Qxidative Stress, but Not Excitotoxic-Related Neuronal Cell Damage—An In Vitro Study
    Danuta Jantas, Monika Leśkiewicz, Magdalena Regulska, Magdalena Procner, Piotr Warszyński, Władysław Lasoń · 2024 · Biomolecules
  11. The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol
    Alice Hartmann dos Santos, Carla Vila-Verde, Francisco Silveira Guimarães, Sâmia R.L. Joca, Sabrina Francesca de Souza Lisboa · 2022 · Current Neuropharmacology
  12. Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses
    Laísa S. Umpierrez, Priscila A. Costa, Eden A. Michelutti, Sarah Jane Baracz, Melanie K. Sauer, Anita J. Turner, Nicholas A. Everett, Jonathon Carl Arnold, Iain S. McGregor, Jennifer L. Cornish · 2022 · Psychopharmacology
  13. Cannabinoids in Health and Disease
    Rosaria Meccariello, Rosanna Chianese · 2016 · InTech eBooks
  14. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial
    Febe E. van der Flier, C. Kwee, Daniëlle C. Cath, Neeltje M. Batelaan, Lucianne Groenink, Puck Duits, Date Claudius van der Veen, Anton J.L.M. van Balkom, Johanna M.P. Baas · 2019 · BMC Psychiatry
  15. Infodemiological Examination of Personal and Commercial Tweets About Cannabidiol: Term and Sentiment Analysis
    Jason Turner, Mehmed M. Kantardzic, Rachel Vickers‐Smith · 2021 · Journal of Medical Internet Research
  16. Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents
    Flávia Pereira Dias Viegas, Vanessa Silva Gontijo, Matheus de Freitas Silva, Cindy Juliet Cristancho Ortiz, Graziella dos Reis Rosa Franco, Januário Tomás Ernesto, Caio Miranda Damásio, Isabela Marie Fernandes Silva, Thâmara Gaspar Campos, Cláudio Viegas · 2021 · Current Neuropharmacology
  17. Stereoselective Synthetic Strategies to (−)‐Cannabidiol
    Alice Maiocchi, Jacopo Barbieri, Valerio Fasano, Daniele Passarella · 2022 · ChemistrySelect
  18. Social stress under binge-like alcohol withdrawal in adolescence: evidence of cannabidiol effect on maladaptive plasticity in rats
    Anna Brancato, Valentina Castelli, Gianluca Lavanco, Cesare D’Amico, Salvatore Feo, Giuseppe Pizzolanti, Martin Kuchař, Carla Cannizzaro · 2022 · Psychological Medicine
  19. Enhanced discriminative stimulus effects of Δ9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys
    Lance Richard McMahon · 2016 · Drug and Alcohol Dependence
  20. The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors
    Kelly A. Sagar, Staci A. Gruber · 2025 · CNS Drugs
  21. Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network
    Francesca Mottarlini, Marco Fumagalli, Fernando Castillo Díaz, Stefano Piazza, Giorgia Targa, Enrico Sangiovanni, Barbara Pacchetti, Mikael Hans Sodergren, Mario Dell’Agli, Fabio Fumagalli et al. · 2022 · Biomedicines
  22. A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
    Matthew Murphy, Simon Erridge, Carl Holvey, Ross Coomber, James Rucker, Mikael Hans Sodergren · 2023 · Neuropsychopharmacology Reports
  23. Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain
    Radu Tănăsescu, Cris S. Constantinescu · 2013 · Expert Opinion on Drug Metabolism & Toxicology
  24. Beneficial effects of cannabidiol from Cannabis
    Sullim Lee, Yunjeong Lee, Yunseo Kim, Hyun Ji Kim, Haerim Rhyu, Kyoung Mi Yoon, Chang-Dae Lee, Sanghyun Lee · 2024 · Applied Biological Chemistry
  25. Cannabidiol in the dorsal hippocampus attenuates emotional and cognitive impairments related to neuropathic pain: The role of prelimbic neocortex-hippocampal connections
    Ana Carolina Medeiros, Priscila Sanjuan de Medeiros, Glauce Regina Pigatto, Sabatino Maione, Norberto Cysne Coimbra, Renato Leonardo de Freitas · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  26. Natural Product-Inspired Dopamine Receptor Ligands
    Michael Dorogan, Namballa Hari Krishna, Wayne Wesley Harding · 2024 · Journal of Medicinal Chemistry
  27. Dose-Dependent Antidepressant-Like Effects of Cannabidiol in Aged Rats
    Elena Hernández‐Hernández, María Julia García-Fuster · 2022 · Frontiers in Pharmacology
  28. Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction
    Jaqueline Maisa Franzen, Felipe Vanz, Isabel Werle, Francisco Silveira Guimarães, Leandro Jose Bertoglio · 2022 · European Neuropsychopharmacology
  29. Preclinical effects of cannabidiol in an experimental model of migraine
    Chiara Sturaro, Bianca Fakhoury, Katarzyna M. Targowska‐Duda, Gilles Zribi, Jennifer Schoch, Chiara Ruzza, Girolamo Calò, Lawrence Toll, Andrea Cippitelli · 2023 · Pain
  30. Cannabidiol Products: Review of the Regulatory and Clinical Considerations
    Emily M. Hawes, Cameron R. Lee, Dana E. Brackney, Tucker G. Ensley, Julie Kidd, Cristen P. Page · 2020 · The Journal for Nurse Practitioners
  31. Cannabidiol Modulates the Motor Profile and NMDA Receptor-related Alterations Induced by Ketamine
    Charalampos Brakatselos, Foteini Delis, Michail-Zois Asprogerakas, Panagiotis Lekkas, Ioulia K. Tseti, Petros S. Tzimas, Eleftherios A. Petrakis, Maria Halabalaki, Alexios‐Léandros Skaltsounis, Katerina Antoniou · 2020 · Neuroscience
  32. A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
    Liu Liu, Jianxing Liu, Ming Zhao, Meiming Cai, Fanzhang Lei, Xiaofeng Zeng, Bofeng Zhu · 2022 · Frontiers in Pharmacology
  33. Impact of conformational and solubility properties on psycho-activity of cannabidiol (CBD) and tetrahydrocannabinol (THC)
    Vitor A. N. Bragança, Tiago Galan de França, Ana Carolina S. P. S. de Jesus, Ivanete Cardoso Palheta, Fernanda P. A. Melo, Paulo Alexandre P. F. G. das Neves, Anderson H. Lima, Rosivaldo S. Borges · 2020 · Chemical Data Collections
  34. Delta‐9‐tetrahydrocannabinol potentiates fear memory salience through functional modulation of mesolimbic dopaminergic activity states
    Aurélie Fitoussi, Jordan S. Zunder, Huibing Tan, Steven R. Laviolette · 2018 · European Journal of Neuroscience
  35. Potential of cannabinoids as treatments for autism spectrum disorders
    Vera Nezgovorova, Casara Jean Ferretti, Bonnie P. Taylor, Emily Catherine Shanahan, Genoveva Uzunova, Kevin Hong, Orrin Devinsky, Eric Hollander · 2021 · Journal of Psychiatric Research
  36. Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain
    Pedro Augusto Lopes Tito, Túlio Cézar de Souza Bernardino, Paula Maria Quaglio Bellozi, Maria Carolina Machado da Silva, Aline Silva de Miranda, Érica Leandro Marciano Vieira, Fabrício A. Moreira, András Palotás, Antônio Carlos Pinheiro de Oliveira, Helton José Reis · 2021 · Pharmacological Reports
  37. Cannabidiol Selectively Binds to the Voltage-Gated Sodium Channel Nav1.4 in Its Slow-Inactivated State and Inhibits Sodium Current
    Chiung-Wei Huang, Pi-Chen Lin, Jianlin Chen, Ming‐Jen Lee · 2021 · Biomedicines
  38. Cannabis consumption and prosociality
    Jacob Miguel Vigil, Sarah See Stith, Tiphanie Chanel · 2022 · Scientific Reports
  39. Cannabis Vaping–Induced Acute Pulmonary Toxicity: Case Series and Review of Literature
    Sreedhar Adapa, Vijay Bhaskar Reddy Gayam, Venu Madhav Konala, Srinadh Annangi, Mina P. Raju, Vishnu Bezwada, Christine McMillan, Hussain Dalal, Amrendra Mandal, Srikanth Naramala · 2020 · Journal of Investigative Medicine High Impact Case Reports
  40. Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus)
    Alexander C. S. Thomson, Taralyn M. McCarrel, Alexander D. Zakharov, Beatriz Gomez, Alex Lyubimov, Wayne S. Schwark, Martha F. Mallicote, Diego A. Portela, Amber Bisiau, Joseph J. Wakshlag · 2024 · Frontiers in Veterinary Science
  41. A comprehensive update on cannabidiol, its formulations and drug delivery systems
    Surojit Banerjee, Vikas Anand Saharan, Debadri Banerjee, Veerma Ram, Hitesh Kulhari, Deep Pooja, Anupama Singh · 2024 · Phytochemistry Reviews
  42. When and How to Treat Possible Cannabis Use Disorder
    Annie Lévesque, Bernard Le Foll · 2018 · Medical Clinics of North America
  43. Cannabidiol-Induced Acute Generalized Exanthematous Pustulosis
    Cory J. Pettit, Susan C. Massick, Mark A. Bechtel · 2018 · Dermatitis
  44. Discovering the Lost Reward: Critical Locations for Endocannabinoid Modulation of the Cortico–Striatal Loop That Are Implicated in Major Depression
    Sari Goldstein Ferber, Aron Weller, Gal Yadid, Alexander Friedman · 2021 · International Journal of Molecular Sciences
  45. Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived Neurons
    Jaume Lillo, Iu Raïch, Laura Silva, David A. Zafra, Alejandro Lillo, Carlos Ferreiro‐Vera, Verónica Sánchez de Medina, José Antonio Martínez-Orgado, Rafael Franco, Gemma Navarro · 2022 · International Journal of Molecular Sciences
  46. Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice
    Paloma Molina Hernandes, Matheus Fitipaldi Batistela, Jefferson Manoel Nascimento‐Silva, Alana Tercino Frias, Melina Matthiesen, Alline Cristina Campos, T.A. Lovick, Hélio Zangrossi · 2023 · Behavioural Brain Research
  47. Cannabidiol effects on fear processing and implications for PTSD: Evidence from rodent and human studies
    Sabrina Francesca de Souza Lisboa, Cristina Aparecida Jark Stern, Lucas Gazarini, Leandro Jose Bertoglio · 2024 · International review of neurobiology
  48. Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder
    Claire Alexander, Maryam Vasefi · 2021 · IBRO Neuroscience Reports
  49. Cannabidiol Reduces Nicotine Withdrawal Severity and State Anxiety During an Acute E-cigarette Abstinence Period: A Novel, Open-Label Study
    L. Riley Gournay, Jordan Petry, Sarah A. Bilsky, Morgan A. Hill, Matthew T. Feldner, Erica N. Peters, Marcel O. Bonn‐Miller, Ellen W. Leen‐Feldner · 2023 · Cannabis and Cannabinoid Research
  50. Cannabidiol induces systemic analgesia through activation of the PI3Kγ/nNOS/NO/KATP signaling pathway in neuropathic mice. A KATP channel S-nitrosylation-dependent mechanism
    Douglas Lamounier de Almeida, Renata Cristina Mendes Ferreira, Flávia Cristina de Sousa Fonseca, Daniel Portela Dias Machado, Danielle Diniz Aguiar, Francisco Silveira Guimarães, Igor Dimitri Gama Duarte, Thiago Roberto Lima Romero · 2024 · Nitric Oxide
  51. In the Swim of Cannabis: Developmental Toxicity and Metabolomic Pathway Alterations of Zebrafish Larvae Exposed to THC for the Assessment of Its Potential Environmental and Human Health Impact
    Theodoros G. Chatzimitakos, Ieremias Chousidis, Dimitrios Leonardos, Constantine D. Stalikas, IOANNIS D. LEONARDOS · 2022 · Molecules
  52. Cannabidiol and 5-HT1A Receptors
    Manoela V. Fogaça, Alline Cristina Campos, Francisco Silveira Guimarães · 2016 · Elsevier eBooks
  53. Motivating intention to take action on behalf of an out-group: implications for the use of advocacy messages in social marketing strategies
    Jane Summers, Jessica Summers · 2017 · Journal of Marketing Management
  54. Characterization of Cannabidiol in Alternative Biological Specimens and Urine, after Consumption of an Oral Capsule
    Alice Ameline, Jean‐Sébastien Raul, Pascal Kintz · 2020 · Journal of Analytical Toxicology
  55. Drogen- und Medikamentenabhängigkeit
    Torsten Kienast, Andreas Heinz, M. Soyka · 2011 · Springer eBooks
  56. The effects of acute Cannabis smoke or Δ9-THC injections on the trial-unique, nonmatching-to-location and five-choice serial reaction time tasks in male Long-Evans rats
    Ilne L. Barnard, Timothy J. Onofrychuk, Thaísa Meira Sandini, Dan L. McElroy, Ayat Zagzoog, Andrew J. Roebuck, Faith V. L. Austin-Scott, Robert B. Laprairie, John G. Howland · 2022 · Neurobiology of Learning and Memory
  57. A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder
    Michael A. Norred, Zachary D. Zuschlag, Mark B. Hamner · 2024 · Drugs
  58. Cannabinoïdes et thérapeutique
    Nicolas Fabresse, Jenny Becam, Laura Carrara, Juliette Descoeur, Mélanie Di Mario, Guillaume Drevin, Thibault Duval, Nassim Hannas, Thomas Lanot, Maude Marillier et al. · 2019 · Annales de Toxicologie Analytique
  59. Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition In Vivo in Rats
    Michiru Nagao, Yukako Nakano, Masataka Tajima, Erika Sugiyama, Vilasinee Hirunpanich Sato, Makoto Inada, Hitoshi Sato · 2020 · Cannabis and Cannabinoid Research
  60. Cannabidiol prevents depressive-like behaviors through the modulation of neural stem cell differentiation
    Ming Hou, Suji Wang, Dandan Yu, Xinyi Lu, Xiansen Zhao, Zhang‐Peng Chen, Chao Yan · 2022 · Frontiers of Medicine
  61. The Relationship between Cannabidiol and Psychosis: A Review
    Thayanne Brandão Guimarães Silva, Cássio Queiroz Balbino, Anderson Fábio Moura Weiber · 2015 · Annals of Clinical Psychiatry
  62. A Novel Anti-Inflammatory Formulation Comprising Celecoxib and Cannabidiol Exerts Antidepressant and Anxiolytic Effects
    Eyal Dinur, Hagar Goldenberg, Elad Robinson, Lior Naggan, Ewa Kozela, Raz Yirmiya · 2022 · Cannabis and Cannabinoid Research
  63. Cannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels
    Adolfo Garcia Erustes, Vanessa Costhek Abílio, Cláudia Bincoletto, Mauro Piacentini, Gustavo J.S. Pereira, Soraya Soubhi Smaili · 2024 · Brain Research
  64. Pharmacokinetics of cannabidiol, (-)-trans-Δ9-tetrahydrocannabinol, and their oxidative metabolites after intravenous and oral administration of a cannabidiol-dominant full-spectrum hemp product to beagle dogs
    Susanna E. Kitts-Morgan, Richard Alvin Sams, William W. Muir · 2025 · Frontiers in Veterinary Science
  65. Women are taking the hit: Examining the unique consequences of cannabis use across the female lifespan
    Erin L. Gräfe, Hannah M. O. Reid, Irene Shkolnikov, K. Conway, Ah Kit, C. Acosta, Brian R. Christie · 2023 · Frontiers in Neuroendocrinology
  66. Cannabidiol and epilepsy
    Fabrício A. Moreira, Antônio Carlos Pinheiro de Oliveira, Victor Rodrigues Santos, Márcio Flávio Dutra Moraes · 2024 · International review of neurobiology
  67. The Development of Cannabinoids as Therapeutic Agents in the United States
    Conor H. Murray, Brenda M. Gannon, Peter John Winsauer, Ziva D. Cooper, Marcus Sherode Delatte · 2024 · Pharmacological Reviews
  68. Cannabidiol Protects against the Reinstatement of Oxycodone-Induced Conditioned Place Preference in Adolescent Male but Not Female Rats: The Role of MOR and CB1R
    Justyna Socha, Paweł Grochecki, Marta Marszałek‐Grabska, Aleksandra Skrok, Irena Smaga, Tymoteusz Słowik, Wojciech Prazmo, Robert Kotlinski, Małgorzata Filip, Jolanta Helena Kotlinska · 2024 · International Journal of Molecular Sciences
  69. Palmitoylethanolamide: From endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence
    Maurizio Coppola, Raffaella Mondola · 2013 · Medical Hypotheses
  70. Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack
    Luara A. Batista, Andréa Siqueira Haibara, Luiz Carlos Schenberg, Fabrício A. Moreira · 2016 · Behavioural Brain Research
  71. Role of Cannabinoids in Various Diseases: A Review
    Arpita Roy, Simran Kaur, Nikita Sharma · 2021 · Current Pharmaceutical Biotechnology
  72. Combination of Cannabidiol with Taurine Synergistically Treated Periodontitis in Rats
    Se Woong Kim, Saroj Kumar Shrestha, Badmaarag‐Altai Chuluunbaatar, Yunjo Soh · 2024 · Biomolecules & Therapeutics
  73. Medicinal Cannabis and the Intestinal Microbiome
    Luis Vitetta, Tamara R. Nation, Debbie Oldfield, Michael Thomsen · 2024 · Pharmaceuticals
  74. Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure
    Einat Karp, Zohar Rubinstein, Rany Abend, Shaul Lev‐Ran, Lia Naor, Mario Mikulincer · 2025 · Journal of Psychopharmacology
  75. Review of the current ongoing clinical trials exploring the possible anti-anxiety effects of cannabidiol
    Rhenu Bhuller, Walter K. Schlage, Julia Hoeng · 2024 · Journal of Cannabis Research
  76. Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors
    Adriana Jesus Souza, Francisco Silveira Guimarães, Felipe V. Gomes · 2023 · Behavioural Brain Research
  77. Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed male mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortex
    Franciele Franco Scarante, Vinícius Detoni Lopes, Eduardo Junji Fusse, Maria Adrielle Vicente, Gabriel H Dias de Abreu, Viviani Nardini, Carlos A. Sorgi, Pedro Henrique Cassaro Lirio, Feng Guo, Hui‐Chen Lu et al. · 2026 · Neuropharmacology
  78. Protective Effects of Two Halophilic Crude Extracts from Pseudomonas zhaodongensis and Bacillus stratosphericus against Memory Deficits and Anxiety‐ and Depression‐Like Behaviors in Methionine‐Induced Schizophrenia in Mice Focusing on Oxidative Stress Status
    Yousra Massaoudi, Jaouad Anissi, Radu Marian Lefter, Andrei Lobiuc, Khalid Sendide, Alin Stelian Ciobica, Mohammed El Hassouni · 2020 · Evidence-based Complementary and Alternative Medicine
  79. Cannabinoids and obsessive-compulsive disorder
    Plinio Cabrera Casarotto, Felipe V. Gomes, Francisco Silveira Guimarães · 2015 · Elsevier eBooks
  80. Behavioral observations, heart rate and cortisol monitoring in horses following multiple oral administrations of a cannabidiol containing paste (part 2/2)
    F. Eichler, Anna Ehrle, Marc Machnik, Katharina Charlotte Jensen, Sabrina Wagner, Natalie Baudisch, Julia Bolk, Magdalena Pötzsch, Mario Thevis, Wolfgang Bäumer et al. · 2024 · Frontiers in Veterinary Science
  81. Clinical Experience of Integrative Autism treatment with a Novel type of Immunotherapy
    Nicola Antonucci, Stefania Pacini, Marco Ruggiero · 2019 · Madridge Journal of Vaccines
  82. Cannabidiol presents an inverted U-shaped dose-response curve in the simulated public speaking test
    Ila Marques Porto Linares · 2016
  83. UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder
    John Julian Warner-Levy, Simon Erridge, Eleanor Clarke, Katy McLachlan, Ross Coomber, Muhammad Sohaib Asghar, Karl Bexley, Urmila Bhoskar, Matthieu Crews, Andrea De Angelis et al. · 2024 · Expert Review of Neurotherapeutics
  84. Quantification of ∆9-tetrahydrocannabinol, 11-OH-THC, THC-COOH, hexahydrocannabinol, and cannabidiol in human plasma and blood by liquid chromatography–tandem mass spectrometry
    Marion Pavlic, Carolin Innerhofer, Florian Pitterl · 2024 · Journal of Analytical Toxicology
  85. Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder
    Luke John Ney · 2025 · International Journal of Molecular Sciences
  86. Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum
    Selen Dirik, Michelle R. Doyle, Courtney P. Wood, Paola Campo, Angelica R. Martinez, McKenzie J. Fannon, Maria G. Balaguer, Spencer Seely, Bryan A Montoya, Gregory M. R. Cook et al. · 2025 · Neuropsychopharmacology
  87. Place of therapeutic cannabis in France and safety data: A literature review
    B. Corso, Astrid Bacle, Elouan Demay, Marion Mercerolle, Romain Pelletier, Thomas Gicquel, Brendan Le Daré · 2023 · Annales Pharmaceutiques Françaises
  88. Cannabidiol as an antipsychotic drug
    Débora Fabris, João Roberto Lisboa, Francisco Silveira Guimarães, Felipe V. Gomes · 2024 · International review of neurobiology
  89. Utilization of Cannabidiol in Post-Organ-Transplant Care
    幸子 小山, Jumar Etkins, Joshua Jun, Matthew Miller, Gerald C. So, Debora L. Gisch, Michael T. Eadon · 2025 · International Journal of Molecular Sciences
  90. Effects of cannabidiol on reward contextual memories induced by cocaine in male and female mice
    Rayssa C. Briânis, Lia P. Iglesias, Lucas G. Bedeschi, Fabrício A. Moreira · 2023 · Acta Neuropsychiatrica
  91. Cannabidiol in anxiety disorders: Current and future perspectives
    João Luís Q. Simei, José Diogo R. Souza, João Roberto Lisboa, Francisco Silveira Guimarães, José Alexandre S. Crippa · 2024 · International review of neurobiology
  92. Pathways Driving Neuroprogression in Depression: The Role of Immune Activation
    Giovanni Oriolo, Iría Grande, Rocío Martín‐Santos, Eduard Vieta, Andre Ferrer Carvalho · 2018 · Elsevier eBooks
  93. New psychoactive substances: An emerging epidemic
    Kranti Kadam · 2019 · Annals of Indian Psychiatry
  94. Cannabinoids and Pain for the Plastic Surgeon
    Kristen L. Stephens, John T. Heineman, Grace L. Forster, Michael Paul Timko, Brent R. DeGeorge · 2022 · Annals of Plastic Surgery
  95. Experimental maturation of pine resin in sediment to investigate the formation of synthetic copal and amber
    Evan Thomas Saitta, Thomas G. Kaye · 2025 · Scientific Reports
  96. Cannabidiol ameliorates the anxiogenic and compulsive-like behaviors induced by chronic consumption of a high-carbohydrate diet in male mice
    Anna Paula Marçal, Nícia Soares, Laila Asth, Fabrício A. Moreira, Adaliene Versiani Matos Ferreira, Daniele Cristina de Aguiar · 2022 · Metabolic Brain Disease
  97. Assessing effects of Cannabis on various neuropathologies: A systematic review
    Suhrud Pathak, Jeyaram Bharathi Jeyabalan, Keyi Liu, Preston Cook, Bennett Lange, Shannon Kim, Rishi M. Nadar, Kiersten Ward, Courtney S. Watts Alexander, Ashwani Kumar et al. · 2024 · Journal of Ayurveda and Integrative Medicine
  98. A journey through cannabidiol in Parkinson’s disease
    Elaine Del-Bel, Núbia Barros, Rafaela Aparecida Ponciano da Silva de Moraes, Bianca Andretto de Mattos, Thaís Antônia Alves-Fernandes, Lorena Borges de Abreu, Glauce Crivelaro Nascimento, Daniela Maria Escobar-Espinal, João Francisco Cordeiro Pedrazzi, Gabrielle A. Jacob et al. · 2024 · International review of neurobiology
  99. Cannabidiol: Pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders
    Pedro Henrique Cassaro Lirio, Priscyla D.M. Gaspari, Alline Cristina Campos · 2024 · International review of neurobiology
  100. Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study
    Surya Sridharan, Simon Erridge, Carl Holvey, Ross Coomber, Wendy Holden, James Rucker, Michael W. Platt, Mikael Hans Sodergren · 2024 · Journal of Pain & Palliative Care Pharmacotherapy